NeoGenomics [NEO] vs Danaher [DHR] Detailed Stock Comparison

NeoGenomics Inc.

NASDAQ
Loading...

Danaher Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: NeoGenomics Inc. wins in 5 metrics, Danaher Corporation wins in 14 metrics, with 0 ties. Danaher Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric NeoGenomics Inc. Danaher Corporation Better
P/E Ratio (TTM) -9.42 34.61 Danaher Corporation
Price-to-Book Ratio 1.22 2.40 NeoGenomics Inc.
Debt-to-Equity Ratio 48.95 37.17 Danaher Corporation
PEG Ratio 0.28 3.84 NeoGenomics Inc.
EV/EBITDA -701.07 17.69 Danaher Corporation
Profit Margin (TTM) -14.85% 14.89% Danaher Corporation
Operating Margin (TTM) -6.56% 22.94% Danaher Corporation
EBITDA Margin (TTM) N/A 22.94% N/A
Return on Equity -12.43% 7.08% Danaher Corporation
Return on Assets (TTM) -2.90% 4.19% Danaher Corporation
Free Cash Flow (TTM) $-21.78M $5.26B Danaher Corporation
Dividend Yield N/A 0.56% N/A
1-Year Return 57.71% -10.25% NeoGenomics Inc.
Price-to-Sales Ratio (TTM) 1.42 5.10 NeoGenomics Inc.
Enterprise Value $1.28B $140.38B Danaher Corporation
EV/Revenue Ratio 1.76 5.67 NeoGenomics Inc.
Gross Profit Margin (TTM) 43.83% 60.34% Danaher Corporation
Revenue per Share (TTM) $6 $35 Danaher Corporation
Earnings per Share (Diluted) $-0.84 $5.16 Danaher Corporation
Beta (Stock Volatility) 1.71 0.99 Danaher Corporation
Short % of Float 6.89% 1.10% Danaher Corporation

NeoGenomics Inc. vs Danaher Corporation Stock Performance Analysis

Loading Price Chart...

NEO
DHR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
NeoGenomics Inc.-0.54%1.28%34.59%34.59%-6.96%-5.70%
Danaher Corporation0.56%-1.32%11.85%-5.38%-20.75%-21.40%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
NeoGenomics Inc.57.71%-33.31%-74.14%39.90%751.15%1,822.41%
Danaher Corporation-10.25%-15.98%-20.94%174.08%416.93%738.84%

Performance & Financial Health Analysis: NeoGenomics Inc. vs Danaher Corporation

MetricNEODHR
Market Information
Market Cap i$1.03B$126.39B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i2,557,6275,174,666
90 Day Avg. Volume i1,885,3724,357,215
Last Close$11.09$181.10
52 Week Range$4.72 - $13.74$160.93 - $242.80
% from 52W High-19.29%-25.41%
All-Time High$61.57 (Feb 15, 2021)$296.06 (Sep 06, 2021)
% from All-Time High-81.99%-38.83%
Growth Metrics
Quarterly Revenue Growth0.11%0.04%
Quarterly Earnings Growth0.11%0.08%
Financial Health
Profit Margin (TTM) i-0.15%0.15%
Operating Margin (TTM) i-0.07%0.23%
Return on Equity (TTM) i-0.12%0.07%
Debt to Equity (MRQ) i48.9537.17
Cash & Liquidity
Book Value per Share (MRQ)$6.49$74.32
Cash per Share (MRQ)$1.23$8.06
Operating Cash Flow (TTM) i$5.23M$6.44B
Levered Free Cash Flow (TTM) i$17.20M$4.57B
Dividends
Last 12-Month Dividend Yield iN/A0.56%
Last 12-Month Dividend iN/A$1.28

Valuation & Enterprise Metrics Analysis: NeoGenomics Inc. vs Danaher Corporation

MetricNEO (Apr 24, 2026)DHR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-9.4234.61
Forward P/E i24.4919.64
PEG Ratio i0.283.84
Price to Sales (TTM) i1.425.10
Price to Book (MRQ) i1.222.40
Market Capitalization
Market Capitalization i$1.03B$126.39B
Enterprise Value i$1.28B$140.38B
Enterprise Value Metrics
Enterprise to Revenue i1.765.67
Enterprise to EBITDA i-701.0717.69
Risk & Other Metrics
Beta i1.710.99
Book Value per Share (MRQ) i$6.49$74.32

Financial Statements Comparison: NeoGenomics Inc. vs Danaher Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricNEO (2025)DHR (2025)
Revenue/Sales i727.33M24.57B
Cost of Goods Sold i413.04M10.05B
COGS % of Revenue i56.8%40.9%
Gross Profit i314.29M14.52B
Gross Margin i43.2%59.1%
Research & Development i37.08M1.60B
Operating Income (EBIT) i-88.13M4.69B
Operating Margin i-12.1%19.1%
EBITDA i-10.94M7.17B
EBITDA Margin i-1.5%29.2%
Pre-Tax Income i-110.27M4.23B
Pre-Tax Income % of Revenue i-15.2%17.2%
Income Tax i-2.24M633.00M
Income Tax % of Revenue i-0.3%2.6%
Net Income (Profit) i-108.03M3.61B
Profit Margin i-14.9%14.7%

Balance Sheet & Liquidity Metrics

MetricNEO (2025)DHR (2025)
Cash & Equivalents i159.62M4.62B
Total Current Assets i376.29M12.76B
Total Current Assets % of Revenue i51.7%51.9%
Total Current Liabilities i88.30M6.81B
Total Current Liabilities % of Revenue i12.1%27.7%
Long-Term Debt i404.68M19.50B
Long-Term Debt % of Revenue i55.6%79.4%
Total Shareholders Equity i836.56M52.54B
Retained Earnings i-433.81M46.89B
Retained Earnings % of Revenue i-59.6%190.9%
Property, Plant & Equipment i182.70M2.14B

Cash Flow Statement Comparison

MetricNEO (2025)DHR (2025)
Operating Cash Flow i-8.44M5.64B
Operating Cash Flow % of Revenue i-1.2%23.0%
Capital Expenditures i-27.01M-1.12B
Free Cash Flow i-21.78M5.26B
FCF Margin i-3.0%21.4%
Debt Repayment i-201.25M-500.00M
Common Stock Repurchase iN/A-3.09B

Short Interest & Institutional Ownership Analysis

MetricNEODHR
Shares Short i7.61M6.94M
Short Ratio i4.861.68
Short % of Float i6.89%1.10%
Shares Outstanding i128.99M707.70M
Float Shares i119.22M630.65M
% Held by Insiders i1.65%10.78%
% Held by Institutions i102.85%85.08%
% Held by Public i-4.50%4.14%

Dividend Analysis & Yield Comparison: NeoGenomics Inc. vs Danaher Corporation

MetricNEODHR
Last 12-Month Dividend iN/A$1.28
Last 12-Month Dividend Yield iN/A0.56%
3-Year Avg Annual Dividend iN/A$10.51
3-Year Avg Dividend Yield iN/A1.11%
3-Year Total Dividends iN/A$31.54
Ex-Dividend DateN/ADec 26, 2025